Insert Therapeutics, Inc Company Profile

12:55 EST 17th December 2018 | BioPortfolio

Insert Therapeutics is focused on designing, developing and commercializing delivery-enhanced therapeutics using our patented class of polymeric delivery systems, which we have called our "CyclosertT" family of linear cyclodextrin-containing polymers. We are developing proprietary CyclosertT-drug conjugates using off-patent compounds that have documented efficacy, but which also have known issues relating to their solubility, stability, undesirable side effects or poor pharmacokinetics that we can improve significantly with CyclosertT


129 N. Hill Ave. , Suite 104
United States of America


Phone: 626.683.7200
Fax: 626.683.7220

News Articles [724 Associated News Articles listed on BioPortfolio]

Aspect, Brightonix to demonstrate SimPET Simultaneous Preclinical PET/MRI Insert at WMIC 2018

The ‘SimPET’ was originally introduced 2 years ago at WMIC 2016, integrating Aspect Imaging’s M7 compact MRI with Brightonix Imaging’s novel PET insert ‘SimPET’. The SimPET insert is The ...

FDA OKs Steroid Insert (Dextenza) for Postop Ocular Pain

Dextenza is the first FDA-approved intracanalicular insert that delivers dexamethasone to treat ocular pain following ophthalmic surgery for up to 30 days with a single insertion. FDA Approvals

Being idealistic is a necessary component in achieving your goals

I am a first-year medical student, and just like some of you once did, the primary reason I am becoming a physician is to really make a difference for my patients by [insert x, y or z]. “Wow, that...

EyePoint Pharmaceuticals' upcoming product launches shift focus away from 1Q miss

The biotech recently received FDA approval of its micro-insert Yutiq to treat uveitis, a type of eye inflammation

Learning from nature's design of mosquito to create painless microneedles

A mosquito can insert a needle-like probe into your skin and draw blood for several minutes without you even noticing.

EyePoint Pharmaceuticals wins approval from FDA for eye-inflammation implant

The approved implant Yutiq is a micro-insert that delivers fluocinolone acetonide to the affected portion of the eye over three years

FDA Panel Approves Insert for Opioid Addicts

New implant would provide opioid addicts a long-lasting alternative to daily oral medication.

EyePoint's Yutiq approved for chronic non-infectious uveitis

Yutiq, or fluocinolone acetonide intravitreal implant, a non-bioerodible intravitreal micro-insert containing 0.18-mg fluocin -More- 

PubMed Articles [513 Associated PubMed Articles listed on BioPortfolio]

Imvexxy--another estradiol vaginal insert for dyspareunia.

Retentive Properties of Two Stud Attachments with Polyetherketoneketone or Nylon Insert in Mandibular Implant Overdentures.

The aim of this study was to compare the retentive properties of an attachment with a nylon insert and an attachment with a polyetherketoneketone (PEKK) insert on two-implant mandibular overdentures d...

Dinoprostone Vaginal Insert: A Review in Cervical Ripening.

Dinoprostone vaginal insert (Cervidil; Propess), a retrievable vaginal pessary containing 10 mg of dinoprostone [prostaglandin E (PGE)] in a controlled-release drug delivery device, is approved in m...

Effect of an Injectable Fluocinolone Acetonide Insert on Recurrence Rates in Noninfectious Uveitis Affecting the Posterior Segment: 12-Month Results.

To assess the safety and efficacy of an intravitreal fluocinolone acetonide insert (FAi) to manage inflammation associated with noninfectious posterior uveitis.

Acceptability, effectiveness and safety of a Renew anal insert in patients who have undergone restorative proctocolectomy with ileal pouch anal anastomosis.

Restorative proctocolectomy has gained acceptance in the surgical management of medically refractive ulcerative colitis and cancer prevention in familial adenomatous polyposis. Incontinence following ...

Clinical Trials [317 Associated Clinical Trials listed on BioPortfolio]

Safety, PK, and PD Study of a Vaginal Insert Containing TAF and EVG

The purpose of this Phase I study is to assess the safety, pharmacokinetics, and pharmacodynamics of a combination vaginal insert containing tenofovir alafenamide (TAF) and elvitegravir (E...

Safety and Efficacy Study of Misoprostol Vaginal Insert for Induction of Labour

The primary objective of the study was assessment of the efficacy of four dose reservoirs (25 mcg, 50 mcg, 100 mcg, 200 mcg) of intravaginal controlled release misoprostol administered for...

An Open-label Extension Study to Evaluate the Safety of the 13 mg Bimatoprost Ocular Insert

This study evaluates the long-term (9-months) safety of the Bimatoprost Ocular Insert in subjects with Glaucoma or Ocular Hypertension. All the subjects will receive Bimatoprost Ocular In...

Safety/Efficacy Study Comparing the Misoprostol Vaginal Insert to Cervidil for Cervical Ripening and Induction of Labor

The purpose of this study is to determine whether the misoprostol vaginal insert (50 mcg and 100 mcg) can safely and effectively speed time to vaginal delivery compared to Cervidil (R) in ...

Early Stability of the Delta-TT Cup With Polyethylene Insert Versus a Ceramic Insert. A RSA Study.

The goal of this study is to study the stability of the Delta-TT cup with polyethylene insert and the Delta-TT cup with ceramic insert both combined with the H-MAX femoral stem by means of...

Companies [1303 Associated Companies listed on BioPortfolio]

Insert Therapeutics, Inc

Insert Therapeutics is focused on designing, developing and commercializing delivery-enhanced therapeutics using our patented class of polymeric delivery systems, which we have called our "CyclosertT"...

Ocular Therapeutix™, Inc.

Ocular Therapeutix, Inc. is a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative therapies for diseases and conditions of the ...

Aeris Therapeutics

Aeris Therapeutics is an emerging medical therapeutics company specializing in the development and commercialization of novel treatments for patients with emphysema and other adva...

Altair Therapeutics, Inc.

Based in San Diego, Altair Therapeutics, Inc. is a privately-held biopharmaceutical company developing novel therapeutics to treat human respiratory diseases. Altair Therap...

Vaxiion Therapeutics, Inc.

Vaxiion is dedicated to the design and development of intelligent drug-delivery technologies with special emphasis on targeted oncology therapeutics. Vaxiion Therapeutics was spun...

More Information about "Insert Therapeutics, Inc" on BioPortfolio

We have published hundreds of Insert Therapeutics, Inc news stories on BioPortfolio along with dozens of Insert Therapeutics, Inc Clinical Trials and PubMed Articles about Insert Therapeutics, Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Insert Therapeutics, Inc Companies in our database. You can also find out about relevant Insert Therapeutics, Inc Drugs and Medications on this site too.

Quick Search


Relevant Topic

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Corporate Database Quicklinks

Searches Linking to this Company Record